Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients

Leuk Lymphoma. 2015 Jun;56(6):1895-6. doi: 10.3109/10428194.2014.974595. Epub 2015 Jan 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / therapeutic use
  • Dexamethasone / therapeutic use*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Glucocorticoids / therapeutic use
  • Humans
  • Lenalidomide
  • Male
  • Middle Aged
  • POEMS Syndrome / blood
  • POEMS Syndrome / drug therapy*
  • POEMS Syndrome / pathology
  • Recurrence
  • Remission Induction
  • Retrospective Studies
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use
  • Time Factors
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / blood

Substances

  • Angiogenesis Inhibitors
  • Glucocorticoids
  • Vascular Endothelial Growth Factor A
  • Thalidomide
  • Dexamethasone
  • Lenalidomide